ArticleBiochemical genetics2026
Overexpression of miR-195-5p Suppresses Gastric Cancer Progression by Regulating LAMP2-Mediated Autophagy.
Article in Biochemical genetics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
MiR-195-5p has been confirmed to be intimately linked to many cancers development, whereas its role in gastric cancer (GC) remains unelucidated. The objective of this study was to explore the potential function and mechanism of miR-195-5p in GC. First, miR-195-5p level in GC was analyzed based on clinical specimens and TCGA database. Then, the function of miR-195-5p in GC cells was detected via CCK-8, clone formation assay, flow cytometry, transwell, and wound healing assay. Subsequently, we explored the possible mechanism of miR-195-5p using KEGG analysis, database analysis, Western blot, and rescue assays. In this research, miR-195-5p was declined in GC and associated to malignant progression of GC. The introduction of miR-195-5p weakened cell growth, metastasis, and facilitated cell apoptosis. KEGG enrichment analysis indicated that miR-195-5p influenced the malignant progression of GC through mechanisms related to autophagy. MiR-195-5p overexpression leads to a diminution in cellular autophagy. Further studies identified that miR-195-5p bound to Lysosome-associated membrane protein 2 (LAMP2). Mechanism studies confirmed that miR-195-5p introduction attenuated cell growth, and this process was rescued by LAMP2 overexpression. Collectively, our work disclosed that miR-195-5p affected the malignant progression of GC by regulating LAMP2-mediated autophagy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.